We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

By MedImaging International staff writers
Posted on 20 Mar 2024
Print article
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents. This MoU aims to create synergy in research and development and market exploration by combining the techniques and marketing capabilities of Samsung Medison and Bracco Imaging. Both companies are considering collaborative research to develop protocols for high-frequency and super-resolution imaging for diagnostic purposes. Samsung Medison is among the world's leading manufacturers of innovative premium ultrasound diagnostic equipment while Bracco Imaging is an innovative global leader delivering end-to-end products and solutions through a comprehensive portfolio that includes precision diagnostic imaging modalities. The two companies are considering collaborative research to develop protocols for high-frequency and super-resolution imaging for diagnostic purposes.

This agreement will also focus on global marketing activities including educating healthcare providers, jointly participating in strategic events, and exploring the possibilities in ultrasound-targeted contrast-enhanced drug delivery technologies in association with pharmaceutical agents. Samsung Medison and Bracco Imaging will collaborate on research to diversify the use of ultrasound contrast agents and enhance image resolution in various settings and specialties. Both companies aim to translate device features into diagnostic and clinical benefits for users and patients, including workflow. Bracco Imaging will integrate its quantitative diagnostic analysis software with Samsung Medison's diagnostic ultrasound equipment to improve image reporting and convenience for medical staff.

"Through this MoU agreement with Bracco and global collaboration, we will strengthen our capability in diagnostic ultrasound field, and create an opportunity to enter future ultrasound treatment field," said Yongkwan Kim, CEO of Samsung Medison. "We are planning to increase diagnostic accuracy and expand applicable scope based on Samsung Medison's various ultrasound clinical application techniques and AI solutions."

"It is truly exciting to usher in a new era of contrast agent utilization through our collaboration with Samsung Medison," added Fulvio Renoldi Bracco, CEO of Bracco Imaging. "I am optimistic that this agreement will lead to groundbreaking technological advances in practical treatment applications that will benefit our patients."

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Mobile Digital X-Ray System
MobileDiagnost wDR 2.1
New
Ultrasound System
ARIETTA 750SE
New
Powered Echocardiography Imaging/Ultrasound Table
Powered Echo

Print article
Radcal

Channels

MRI

view channel
Image: The artificial intelligence model outperformed clinical tests at predicting the progress of Alzheimer’s disease (Photo courtesy of 123RF)

AI Outperforms Clinical Tests at Predicting Alzheimer’s Progress from MRI Scans

Dementia is a major global health challenge, impacting over 55 million individuals worldwide and costing approximately USD 820 billion annually. Projections indicate that the number of cases will nearly... Read more

Ultrasound

view channel
Image: The new FDA-cleared AI-enabled applications have been integrated into the EPIQ CVx and Affiniti CVx ultrasound systems (Photo courtesy of Royal Philips)

Next-Gen AI-Enabled Cardiovascular Ultrasound Platform Speeds Up Analysis

Heart failure is a significant global health challenge, affecting approximately 64 million individuals worldwide. It is associated with high mortality rates and poor quality of life, placing a considerable... Read more

General/Advanced Imaging

view channel
Image: The NeuroLF ultra-compact brain Positron Emission Tomography (PET) scanner (Photo courtesy of Positrigo)

Breakthrough Brain PET System Aids Diagnosis of Neurological Disorders

Alzheimer's disease (AD) is the most prevalent type of dementia, representing approximately 70% of all dementia cases in individuals over 60 years of age. As of 2020, there were more than 55 million people... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.